HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Neuropharmacological profile of FrPbAII, purified from the venom of the social spider Parawixia bistriata (Araneae, Araneidae), in Wistar rats.

Abstract
The aims of the present study were to investigate the anticonvulsant activity and behavioral toxicity of FrPbAII using freely moving Wistar rats. Moreover, the effectiveness of this compound against chemical convulsants was compared to that of the inhibitor of the GABAergic uptake, nipecotic acid. Our results show that FrPbAII was effective against seizures induced by the i.c.v. injection of pilocarpine (ED(50) = 0.05 microg/animal), picrotoxin (ED(50) = 0.02 microg/animal), kainic acid (ED(50) = 0.2 microg/animal) and the systemic administration of PTZ (ED(50) = 0.03 microg/animal). The anticonvulsant effect of FrPbAII differed from that of nipecotic acid in potency, as the doses needed to block the seizures were more than 10 folds lower. Toxicity assays revealed that in the rotarod, the toxic dose of the FrPbAII is 1.33 microg/animal, and the therapeutic indexes were calculated for each convulsant. Furthermore, the spontaneous locomotor activity of treated animals was not altered when compared to control animals but differed from the animals treated with nipecotic acid. Still, FrPbAII did not induce changes in any of the behavioral parameters analyzed. Finally, when tested for cognitive impairments in the Morris water maze, the i.c.v. injection of FrPbAII did not alter escape latencies of treated animals. These findings indicate that the novel GABA uptake inhibitor is a potent anticonvulsant with mild side-effects when administered to Wistar rats.
AuthorsErica Aparecida Gelfuso, Alexandra Olimpio Siqueira Cunha, Marcia Renata Mortari, Jose Luiz Liberato, Karina Haddad Paraventi, Rene Oliveira Beleboni, Joaquim Coutinho-Netto, Norberto Peporine Lopes, Wagner Ferreira dos Santos
JournalLife sciences (Life Sci) Vol. 80 Issue 6 Pg. 566-72 (Jan 16 2007) ISSN: 0024-3205 [Print] Netherlands
PMID17083949 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • 2-amino-5-ureidopentanamide
  • Anticonvulsants
  • Receptors, GABA
  • Spider Venoms
  • Urea
Topics
  • Animals
  • Anticonvulsants (adverse effects, isolation & purification, pharmacology, therapeutic use)
  • Behavior, Animal (drug effects)
  • Disease Models, Animal
  • Male
  • Maze Learning (drug effects)
  • Motor Activity (drug effects)
  • Rats
  • Rats, Wistar
  • Receptors, GABA (metabolism)
  • Seizures (drug therapy, physiopathology)
  • Spider Venoms (chemistry)
  • Spiders
  • Urea (adverse effects, analogs & derivatives, isolation & purification, pharmacology, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: